Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Can-Fite BioPharma Ltd. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 114.4K | 131.3K | +16.9K (+14.8%) |
| Value | $185.9K | $193.9K | +$7.94K (+4.3%) |
New holders (5)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 15,271 | $22.6K | 0.00% |
| Virtu Financial LLC | 13,740 | $20.0K | 0.00% |
| Captrust Financial Advisors | 10,634 | $15.7K | 0.00% |
| Costello Asset Management, INC | 1,000 | $1.48K | 0.00% |
| Avion Wealth | 100 | $0 | 0.00% |
Sold out (4)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 19,395 | $31.5K |
| Kohmann Bosshard Financial Services, LLC | 3,401 | $5.53K |
| Citigroup Inc | 553 | $899 |
| Advisor Group Holdings, Inc. | 180 | $293 |